학술논문

Real-world clinical outcomes with poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitors as second-line maintenance therapy in patients with recurrent ovarian cancer in the United States
Document Type
Journal
Source
GYNECOLOGIC ONCOLOGY; AUG 2022, 166 pS180-pS181, 3p. Supplement: 1
Subject
Language
English
ISSN
10956859